Glia-enriched stem-cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis

Francesca Fagiani, Edoardo Pedrini, Stefano Taverna, Elena Brambilla, Valentina Murtaj, Paola Podini, Francesca Ruffini, Erica Butti, Clarissa Braccia, Annapaola Andolfo, Roberta Magliozzi, Lena Smirnova, Tanja Kuhlmann, Angelo Quattrini, Peter A. Calabresi, Daniel S. Reich, Gianvito Martino, Paola Panina‐Bordignon, Martina AbsintabioRxiv 2024 · DOI

TL;DR

Researchers have developed a novel 3D human brain organoid model that incorporates microglia and mimics key inflammatory and neurodegenerative aspects of multiple sclerosis (MS). This model, when exposed to MS patient cerebrospinal fluid (CSF), accurately replicates disease phenotypes, offering a powerful new tool for studying MS and screening potential therapies.

What Problem Does This Paper Address?

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) where glial cells (like microglia and oligodendrocytes) play a critical role in disease progression. However, existing preclinical models often fail to fully capture the complex interactions between these glial cells and the inflammatory environment seen in chronic active MS lesions. Specifically, there's a need for models that can recapitulate the "smoldering" or slow, continuous progression of MS, which is driven by sustained neuroinflammation and glial dysfunction. This paper aims to address this gap by creating a more sophisticated in vitro model that better reflects the human CNS environment in MS.

Methods

The core of this study is the development of a 3D hiPSC-derived brain organoid model. Key methodological innovations include:

  • SOX10-driven Oligodendrogenesis: They utilized a single transcription factor, SOX10, to efficiently accelerate the differentiation of oligodendrocyte precursor cells (OPCs) from human induced pluripotent stem cell (hiPSC)-derived neural progenitor cells (NPCs). This allowed for the generation of organoids with a richer glial component, including mature oligodendrocytes (OLs).
  • Integration of hiPSC-derived Microglia: To achieve immunocompetence, they incorporated hiPSC-derived microglia into the organoids, creating "assembloids." This is crucial for studying glial-immune interactions.
  • Self-Organizing Forebrain Organoids: The protocol generates self-organizing forebrain organoids that spatially and temporally overlap various CNS cell types (neurons, astrocytes, oligodendroglia, and microglia), mimicking the complexity of the human brain.
  • Single-Cell RNA Sequencing (scRNA-seq): Extensive scRNA-seq was performed to comprehensively characterize the cellular diversity and transcriptional profiles of the organoids, comparing them to adult human brain atlases and MS lesion data.
  • Exposure to MS-Inflamed CSF: A critical step involved exposing these organoids to cerebrospinal fluid (CSF) from MS patients. This allowed researchers to study the organoids' response to a complex inflammatory milieu.
  • Pseudotime Trajectory Analysis: This algorithm was used to map the developmental pathways of NPC-derived cells within the organoids, revealing distinct neuronal and glial differentiation routes.
  • CellChat Analysis: This tool was employed to infer and analyze cell-to-cell communication networks within the organoids, shedding light on how different cell types interact.

Datasets

  • Human iPSC Lines: Used for generating NPCs and subsequently the organoids.
  • Human Primary Motor Cortex Atlas: Used for reference-based mapping of organoid cell types to validate their similarity to adult human brain cells.
  • Fetal Human Brain Atlas: Also used for reference-based mapping.
  • Published snRNA-seq Datasets from MS Brain Tissue: Specifically, data from chronic active MS lesions were used to compare organoid microglia and astrocyte profiles to those found in actual MS lesions.
  • Published snRNA-seq Datasets from Cortical Organoids: Used to highlight the differences between their model and existing cortical organoid platforms.
  • CSF Samples: Collected from both healthy controls and MS patients for experimental exposure.

Key Insights and Ideas

  • SOX10 is a powerful driver for glial development: The study demonstrates that SOX10 can efficiently promote oligodendrogenesis in hiPSC-derived NPCs, leading to a more robust glial population in organoids within a shorter timeframe (8 weeks) compared to other methods.
  • Microglia integration is key for immunocompetence: The inclusion of hiPSC-derived microglia is essential for the organoids to mimic the immune responses and glial-immune crosstalk observed in MS.
  • Organoids recapitulate MS-specific glial phenotypes: Exposure to MS-inflamed CSF triggers neurodegenerative phenotypes in the organoids, particularly affecting oligodendrocytes, mirroring what happens in chronic active MS lesions.
  • CSF mediators are critical drivers of neurodegeneration: The data strongly suggest that soluble factors in MS CSF play a significant role in initiating downstream events that lead to oligodendrocyte death and neuroinflammation.
  • A simplified yet powerful model: While not perfectly replicating the entire brain's complexity (e.g., lacking vasculature), this organoid model offers a simplified yet highly relevant platform for studying specific aspects of MS pathology, particularly glial-immune interactions.

Key Results

  • Efficient Glial Differentiation: The SOX10-based protocol successfully generated organoids with a significant and heterogeneous pool of oligolineage cells, including OPCs and mature OLs, within 8 weeks.
  • Mature Cell Types: Organoids exhibited single-cell transcriptional profiles similar to the adult human brain.
  • MS-CSF Mimicry: Exposure to MS-inflamed CSF led to a nearly 50% reduction in MBP+ oligodendrocytes within 6 days, indicating their vulnerability to the inflammatory environment.
  • Transcriptional Overlap with MS Lesions: hiMicroglia in the organoids showed transcriptional profiles that partially overlapped with microglia from chronic active MS lesions, particularly in genes related to iron metabolism and inflammation.
  • Cell-to-Cell Communication Insights: CellChat analysis revealed altered communication patterns between glial cells and neurons in response to MS CSF, highlighting the complex interplay driving neuroinflammation.

Limitations and Future Work

  • Simplified Architecture: The organoid model lacks vascular cells and the complex cytoarchitecture of the human brain.
  • Limited Donor Diversity: The study used a relatively small number of hiPSC lines (5 lines from 2 controls and 3 MS cases), and increasing donor diversity would be beneficial for assessing inter-individual variability.
  • Microglia Survival: Microglia have a limited survival time in culture, which may restrict the ability to model very chronic inflammatory conditions.
  • Future Directions: The authors suggest that this scalable platform is ideal for genetic and small molecule screens to identify novel therapeutics and to further investigate the key regulators of myelination and chronic neurodegeneration in MS. Future work could focus on establishing more chronically inflamed organoid models and generating multi-donor organoids to overcome inter-organoid variability.

Summary updated

Abstract

SUMMARY The role of central nervous system (CNS) glia in sustaining self-autonomous inflammation and driving clinical progression in multiple sclerosis (MS) is gaining scientific interest. We applied a single transcription factor ( SOX10 )-based protocol to accelerate oligodendrocyte differentiation from hiPSC-derived neural precursor cells, generating self-organizing forebrain organoids. These organoids include neurons, astrocytes, oligodendroglia, and hiPSC-derived microglia to achieve immunocompetence. Over 8 weeks, organoids reproducibly generated mature CNS cell types, exhibiting single-cell transcriptional profiles similar to the adult human brain. Exposed to inflamed cerebrospinal fluid (CSF) from MS patients, organoids properly mimic macroglia-microglia neuro-degenerative phenotypes and intercellular communication seen in chronic active MS. Oligodendrocyte vulnerability emerged by day 6 post-MS-CSF exposure, with nearly 50% reduction. Temporally-resolved organoid data support and expand on the role of soluble CSF mediators in sustaining downstream events leading to oligodendrocyte death and inflammatory neurodegeneration. Such findings support implementing this organoid model for drug screening to halt inflammatory neurodegeneration.
BibTeX
@misc{fagiani2024glia,
  author = {Francesca Fagiani and Edoardo Pedrini and Stefano Taverna and Elena Brambilla and Valentina Murtaj and Paola Podini and Francesca Ruffini and Erica Butti and Clarissa Braccia and Annapaola Andolfo and Roberta Magliozzi and Lena Smirnova and Tanja Kuhlmann and Angelo Quattrini and Peter A. Calabresi and Daniel S. Reich and Gianvito Martino and Paola Panina‐Bordignon and Martina Absinta},
  title = {{Glia-enriched stem-cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis}},
  year = {2024},
  doi = {10.1101/2024.06.20.597748},
  howpublished = {bioRxiv},
}
Figure